Filing Manager
BAYER HEALTHCARE LLC
Reporting Manager
Bayer HealthCare LLC
Symbol
SNTI
Shares outstanding
34,471,650 shares
Disclosed Ownership
6,142,848 shares
Ownership
18%
Form type
SCHEDULE 13D/A
Filing time
16 Apr 2026, 16:50:40 UTC
Date of event
27 Mar 2026

Key filing fact

BAYER HEALTHCARE LLC disclosed 18% ownership in Senti Biosciences, Inc. Common Stock, par value $0.0001 per share (SNTI) on 27 Mar 2026.

Key facts

  • BAYER HEALTHCARE LLC filed SCHEDULE 13D/A for Senti Biosciences, Inc. Common Stock, par value $0.0001 per share (SNTI).
  • Disclosed ownership: 18%.
  • Date of event: 27 Mar 2026.

Change

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 16 Apr 2026, 16:50.

Research use

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting persons

Reporting managers (4)

Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Bayer HealthCare LLC 18% 6,142,848 0 6,142,848 /s/ Priyal Patel Priyal Patel, President 0001231517
Bayer US Holding LLC 18% 6,142,848 0 6,142,848 /s/ Sebastian Guth Sebastian Guth, President 0001965754
Sebastian Guth 18% 6,142,848 0 6,142,848 /s/ Sebastian Guth Sebastian Guth
Priyal Patel 18% 6,142,848 0 6,142,848 /s/ Priyal Patel Priyal Patel
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .